A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome
DOI: 10.1016/j.cgh.2026.04.014Author: Allen Lee et al.Published: 2026-4

Forum › Forums › Available Download: › DOI › A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome

DOI: 10.1016/j.cgh.2026.04.014Author: Allen Lee et al.Published: 2026-4

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 28, 2026 at 11:55 am #1459
    dennisfremontdennisfremont
    Member

    Title: A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome
    Journal: Clinical Gastroenterology and Hepatology
    Authors: Allen Lee, Krishna Rao, Prashant Singh, Jared Fehlman, Jun Gao, Will Takakura, Amanda Lynett, Emily Haller, Sarah Ball, Alicia Marand, Amy Liu, Eric Shah, Stacy Menees, Raani Punglia, Borko Nojkov, Shanti Eswaran, Jason Baker, William D. Chey, Chung Owyang, Vincent Young, William L. Hasler
    Date: 2026-4
    DOI: 10.1016/j.cgh.2026.04.014
    Source: Elsevier BV
    Source URL: https://doi.org/10.1016/j.cgh.2026.04.014

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.